If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Holding(s) in Company

5 Jun 2009 12:38

RNS Number : 4577T
Aortech International PLC
05 June 2009
 



TR-1(i)NOTIFICATION OF MAJOR INTERESTS IN SHARES

1.  Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

AorTech International Plc

2.  Reason for the notification (please state Yes/No): ( )

An acquisition or disposal of voting rights: ( )

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to

which voting rights are attached: ( )

An event changing the breakdown of voting rights: ( )

Other (please specify)( Yes )

Disclosure due to new DTR 5.3 Rule 

3.  Full name of person(s) subject to the notification obligation:

GAM UK Hedge Investments Inc

4.  Full name of shareholder(s) (if different from 3.):

5.  Date of the transaction (and date on which the threshold is crossed or reached if different):

  1 June 2009

6.  Date on which issuer notified:

2 June 2009

7.  Threshold(s) that is/are crossed or reached:

3%

8.  Notified details:

A:  Voting rights attached to shares:

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Number of shares

Number of voting Rights 

GB0033360586

Resulting situation after the triggering transaction (vii)

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights 

% of voting rights

Direct

Direct (x)

Indirect (xi)

Direct

Indirect

GB0033360586

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration Date

Exercise/Conversion Period 

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 

Resulting situation after the triggering transaction (xii)

Type of financial instrument

Exercise price

Expiration date

Exercise/Conversion Period

Number of voting rights instrument refers to 

% of voting rights 

Nominal 

Delta

CFDs

150,957

3.124%

1

Total (A+B+C)

Number of voting rights

% of voting rights

150,957

3.124%

9.  Chain of controlled undertakings through which the voting rights and/or the financial instruments are

effectively held, if applicable (xv):

GAM UK Hedge Investments Inc: 150,957 CFDs, 3.124% 

Proxy Voting:

10.  Name of the proxy holder:

Institutional Shareholder Services 

11.  Number of voting rights proxy holder will cease to hold:

12.  Date on which proxy holder will cease to hold voting rights:

13.  Additional information:

14.  Contact name:

15 Contact number:

A: Identity of the persons or legal entity subject to the notification obligation

Full name:

GAM UK Hedge Investments IncContact address 

12 St. James's Place

London

SW1A 2NX

Phone number & email:

Other useful information (at least legal representative for legal persons):

B: Identity of the notifier, if applicable (xvii)

Full name:

Jeannot Huijen

Contact address:As above 

Phone number:

020 7917 2254

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUUMWQUPBGGA
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.